Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 November 1993 | Volume 119 Issue 10 | Pages 992-1000
Objective: To examine the temporal relationship between stopping smoking and total mortality rates among middle-aged women.
Design: Prospective cohort study with 12 years of follow-up.
Setting: Registered nurses residing in the United States.
Participants: 117 001 female registered nurses, ages 30 to 55 years, who were free of manifest coronary heart disease, stroke, and cancer (except nonmelanoma skin cancer) in 1976.
Main Outcome Measures: Total mortality, further categorized into deaths from cardiovascular diseases, cancers, and violent deaths.
Results: A total of 2847 deaths (933 among "never smokers," 799 among former smokers, and 1115 among current smokers) occurred during 1.37 million person-years of follow-up. The multivariate relative risks for total mortality compared with never smokers were 1.87 (95% CI, 1.65 to 2.13) for current smokers and 1.29 (CI, 1.14 to 1.46) former smokers. Participants who started smoking before the age of 15 years had the highest risks for total mortality (multivariate relative risk, 3.15; CI, 2.16 to 4.59), cardiovascular disease mortality (relative risk, 9.94; CI, 5.15 to 19.19), and deaths from external causes of injury (relative risk, 5.39; CI, 1.84 to 15.78). Compared with continuing smokers, former smokers had a 24% reduction in risk for cardiovascular disease mortality within 2 years of quitting. The excess risks for total mortality and both cardiovascular disease and total cancer mortality among former smokers approached the level of that for never smokers after 10 to 14 years of abstinence. The health benefits of cessation were clearly present regardless of the age at starting and daily number of cigarettes smoked.
Conclusions: The risk of cigarette smoking on total mortality among former smokers decreases nearly to that of never smokers 10 to 14 years after cessation.
Further, most large prospective studies with data on smoking cessation have been based solely on men [5, 8, 10]. The British female doctors study [11] had insufficient data to characterize the relationship between time since quitting and decrease in mortality.
We analyzed the health benefits of smoking cessation in the Nurses' Health Study, a large prospective cohort of women in the United States. Our results describe the timing and extent of decrease in risks for total and cause-specific mortality for women who stopped smoking.
The Nurses' Health Study cohort was established in 1976, when 121 700 female registered nurses ages 30 to 55 years completed a mailed questionnaire requesting information about risk factors for cancer and coronary heart disease, including current and past smoking habits, past history of myocardial infarction, angina, cancer, diabetes, hypertension, high serum cholesterol levels, menopause, and parental history of myocardial infarction. Questions were also included on height, weight, postmenopausal use of hormones, and history of oral contraceptive use. Since 1976, follow-up questionnaires have been mailed every 2 years to update information on smoking behavior, other cardiovascular risk factors, and the development of major illness. If no questionnaire was returned during the follow-up years, the most recent record of exposure status was used for the subsequent follow-up interval (for smoking-related variables, this occurred in less than 0.5% of the cohort). Further details of the Nurses' Health Study have been published previously [12, 13].
Exposure Data
Women were categorized according to their smoking status as "never smokers," current smokers, or former smokers. Current smokers were further classified as smoking 1 to 4, 5 to 14, 15 to 24, 25 to 34, 35 to 44, or 45 or more cigarettes per day. On the 1976 questionnaire, smokers were asked the age at which they started to smoke. In our analysis, current and former smokers were classified as starting smoking at less than 15 years, between 15 and 17 years, 18 and 21 years, 22 and 25 years, or at age 26 years or older. For time since stopping, former smokers were categorized as having stopped for fewer than 2 years, between 2 and 4 years, 5 and 9 years, 10 and 14 years, or for more than 15 years.
Alcohol intake may potentially confound the association between cigarette smoking and risk for total mortality because smokers tend to drink more, and alcohol intake is associated with reduced risk for cardiovascular disease mortality [14, 15]. In 1980, we assessed the average frequency of alcohol intake during the preceding year. The levels of alcohol intake were categorized into 0 g/d, 0.01 to 4.9 g/d, 5.0 to 14.9 g/d, 15.0 to 24.9 g/d, and 25.0 to 49.9 g/d. The validity of self-reported alcohol intake is high, as reported in detail previously [16, 17].
Vigorous physical activity may also potentially confound the association between smoking and total mortality because smokers tend to exercise less, whereas exercise reduces the risk for cardiovascular disease [18]. We identified women taking part in regular vigorous exercise by asking the following question in the 1980 questionnaire: "At least once a week, do you engage in any regular activity similar to brisk walking, jogging, bicycling, et cetera, long enough to work up a sweat?" The validity of this item as a measure of physical activity has been discussed previously [19].
End Points
The end points in our study comprised deaths from all causes occurring after the 1976 questionnaire was returned but before 1 June 1988. The deaths were further grouped into four broad categories: total cardiovascular diseases (ICD 8th revision codes 410 to 440 and 795); total cancers (ICD 8th revision codes 140 to 207); total cancers excluding lung cancer (ICD 8th revision codes 140 to 161 and 163 to 207); and external causes of injury (all ICD "E" codes), which included accidents and suicides.
The mortality surveillance included systematic searches of the vital records of the states and the National Death Index to discover deaths among women who did not respond during each questionnaire cycle. This search was supplemented by reports from relatives and postal authorities. We estimate that more than 98% of the deaths in the cohort were ascertained by these methods [20].
Physicians reviewed death certificates to classify individual causes of death. Deaths caused by cancer, cardiovascular disease, and external injury were classified as confirmed if they were listed as the underlying causes on the death certificate.
Statistical Analysis
The primary analysis of follow-up data from 1976 to 1988 used incidence rates with person-years of follow-up as the denominator. For each participant, person-years were allocated according to the 1976 exposure variables and were updated according to information on biennial follow-up questionnaires. For women who died, person-years were assigned according to the covariate status reported in the most recently completed questionnaire; follow-up was terminated at the date of death.
Relative risks were calculated as the rate of death in each smoking category divided by the corresponding rate in the reference category. For analyses evaluating the relative risk for mortality among current smokers, we used the never smokers as the reference category. To assess the effect on mortality risk among former smokers by time since stopping, we followed the suggestion of the 1990 Surgeon General's report [7] and used current smokers as the reference category. All relative risks were age-adjusted by 5-year intervals, and 95% CIs were calculated [21]. The attributable risk for mortality (that is, the excess number of deaths attributable to smoking per 100 000 person-years) was calculated as the difference between the mortality rates between current (or former) smokers and never smokers. When appropriate, we performed the Mantel test for linear trend across categories of smoking variables and reported the two-tailed P values [22]. We also used proportional hazards models to control simultaneously for age, cigarette smoking, and other risk factors for cardiovascular disease and cancer.
Previous reports have indicated that former smokers tend to have smoked fewer cigarettes per day [7] and to have started smoking at an older age than continuing smokers [23]. Thus, at any age of quitting, former smokers have less cumulative exposure to cigarettes, on average, than continuing smokers. Failure to adjust for differences in cumulative exposure between former and current smokers may therefore exaggerate the benefits of cessation. Wherever appropriate, we adjusted the relative risks for death among former smokers by the daily number of cigarettes smoked and the age at which they started.
We excluded from analysis all women who had reported angina, myocardial infarction, stroke, and cancer (other than nonmelanoma skin cancer) at baseline. These exclusions left a total cohort of 117 001 women available for follow-up.
Confounding by Intermediate Variables
In a prospective study involving repeated measurement of smoking status, nonfatal disease may act simultaneously as a confounding factor and an intermediate variable in the pathway between smoking and mortality [24, 25]. For example, in analyzing the relation between smoking and coronary heart disease mortality, intervening morbid events (such as nonfatal myocardial infarction or angina) may act both as a determinant of subsequent exposure to smoking and as an independent risk factor for subsequent death from coronary heart disease. We assessed the extent of such confounding by performing the G-computational algorithm, as described by Robins [24, 25], on the relation between cigarette smoking and fatal coronary heart disease, using nonfatal myocardial infarction and angina in the analysis as the time-dependent covariates.
In 1976, 33.2% of the cohort members were current smokers; 43.3%, never smokers; and 23.5%, former smokers. By 1988, the corresponding proportions were 22.1%, current; 42.6%, never; and 35.3%, former smokers. Some, but not all, health-related habits were distributed similarly between never, current, and former smokers (Table 1). Compared with never smokers, current smokers tended to engage less frequently in vigorous exercise, to have slightly lower body mass index, and to be more likely to drink more than 15 g/d of alcohol. ARTICLE
Smoking Cessation in Relation to Total Mortality Rates in Women: A Prospective Cohort Study
Former smokers are at lower risk for total mortality compared with continuing smokers [1-8]. However, the time required for the risk for total mortality among quitters to reach the level of never smokers differs among studies, ranging from 6 to 10 years in one study [9] to 15 or more years in other studies [7, 10]. Few previous studies have been able to examine the temporal relationship between smoking cessation and decline in mortality risk while adjusting for other smoking-related factors, such as age at starting and number of cigarettes smoked.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
The Nurses' Health Study Cohort
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Characteristics of Smokers
|
Causes of Death
During the 12 years of observation, 2847 deaths occurred in 1 374 556 person-years: Five hundred sixty-six persons died of cardiovascular diseases, 247 of lung cancer, 1209 of cancers excluding lung cancer; 261 from external causes of injury, and 564 of other causes. The category of external causes of injury covers the 8th revision International Classification of Diseases codes E800 to E999 and includes all deaths from accident, poisoning, suicide, and other trauma [26].
Risks of Current Smokers
Total Mortality
Compared with women who had never smoked, current smokers had higher rates of total mortality (age-adjusted relative risk, 1.86; CI, 1.71 to 2.03) (Table 2). The age-adjusted relative risk increased with the number of cigarettes smoked per day (P < 0.0001). Women who smoked 35 to 44 cigarettes per day had a relative risk for total mortality of 2.42 (CI, 2.01 to 2.90), whereas women who smoked 45 or more cigarettes per day had a relative risk of 3.57 (CI, 2.52 to 5.04). The attributable risk for total mortality in current smokers compared with never smokers was 120 per 100 000 person-years. Approximately 37% of all deaths among current smokers in this cohort were attributable to cigarette smoking.
|
Cause-specific Mortality
The age-adjusted relative risk for cardiovascular disease mortality among current smokers was 3.47 (CI, 2.85 to 4.22), and the risk increased with the number of cigarettes smoked daily (P = 0.002) (Table 2). Women who smoked only one to four cigarettes per day had an elevated risk for death from cardiovascular disease (relative risk, 2.13; CI, 1.20 to 3.79), and those who smoked 45 or more cigarettes per day had a relative risk of 6.35 (CI, 3.26 to 12.34).
For total cancer mortality including lung cancer, the overall age-adjusted relative risk among current smokers was 1.51 (CI, 1.33 to 1.70), and risk increased with the daily number of cigarettes smoked (P < 0.001). When lung cancers were excluded, however, the relative risk for cancer mortality among current smokers was not statistically significantly elevated (relative risk, 1.10; CI, 0.96 to 1.26), and no dose-response relationship with the number of cigarettes smoked daily was found (P > 0.2) (see Table 2). This finding is explained by the fact that breast and colorectal cancer, two of the most common cancers in this cohort, had no association with cigarette smoking. The relative risk for deaths caused by breast cancer among current smokers was 0.87 [CI, 0.68 to 1.12] and it was 1.01 for colorectal cancer (CI, 0.69 to 1.46). On the other hand, the weak association between current smoking and total cancer after excluding lung cancer did not preclude the presence of strong associations between smoking and mortality from the less common cancers of individual sites, such as cancers of the buccal cavity and pharynx (six cases among current smokers; age-adjusted relative risk, 5.0; CI, 1.2 to 20.7), esophagus (seven cases among current smokers; age-adjusted relative risk, 11.1; CI, 2.1 to 58.9), and pancreas (26 cases among current smokers; age-adjusted relative risk, 1.9; CI, 1.1 to 3.4).
The age-adjusted relative risk for death from external causes of injury among current smokers was 1.69 (CI, 1.28 to 2.24), and risk increased with the daily number of cigarettes smoked (P = 0.001).
Multivariate Models
The associations of cigarette smoking with total and cause-specific mortality changed only slightly after we controlled for potential confounders (including history of hypertension, diabetes, high serum cholesterol, relative body weight, parental history of myocardial infarction before the age of 60 years, past use of oral contraceptives, postmenopausal estrogen therapy, and age at starting smoking) in multivariate proportional-hazards models (see Table 2).
Decrease in Risk among Former Smokers
Total Mortality
Compared with never smokers, the age-adjusted relative risk for total mortality among former smokers was 1.28 (CI, 1.16 to 1.40). When we examined the relation between time since quitting and the relative risk for total mortality, the risk among former smokers approached the level of never smokers 10 to 14 years after cessation (Table 3); (Figure 1).
|
|
In terms of absolute risk, if 1000 women ages 40 to 44 years quit smoking today, approximately 17 deaths would occur in that group during the next 14 years, compared with 30 deaths if they had continued smoking; that is, a net saving of 13 lives per 1000 women during a 14-year period. The absolute benefits of cessation increase with age. If 1000 women 60 years or older quit smoking today, approximately 103 deaths would occur during a period of 14 years, compared with 138 deaths if they had continued smoking; that is, a net saving of 35 lives per 1000 women.
A slight and nonsignificant increase in relative risk was apparent in the category of former smokers who had quit for more than 15 years compared with those who had quit for 10 to 14 years. This finding was compatible with chance, however, because the 95% confidence intervals of the relative risks beyond 10 years after cessation excluded the point estimates of the risks among former smokers who had quit for shorter durations, but we cannot exclude the possibility that a small excess in risk extends beyond 15 years of abstinence.
Cause-specific Mortality
A 24% reduction in the risk for mortality from cardiovascular disease was apparent within 2 years of giving up cigarettes; however, the excess risk did not approach the level of never smokers until 10 to 14 years after cessation. For deaths from external causes of injury, the age-adjusted relative risks among former smokers decreased to the level of never smokers 5 to 9 years after cessation (Table 3).
A greater risk for total cancer was observed among former smokers compared with current smokers in the first 2 years after cessation (age-adjusted relative risk, 1.42; CI, 1.12 to 1.81). The excess risk decreased to the level of never smokers after 10 to 14 years of abstinence. However, when lung cancer was excluded from the analysis of total cancer mortality, an excess risk was apparent only within the first 2 years after quitting (age-adjusted relative risk, 1.35; CI, 1.00 to 1.81) (Table 3).
The observations regarding the relationship of time since quitting with the risks of total and cause-specific mortality remained unchanged after controlling for potential confounding factors, including history of hypertension, diabetes, high serum cholesterol, relative body weight, parental history of myocardial infarction before age 60 years, past use of oral contraceptives, postmenopausal estrogen therapy, the daily number of cigarettes smoked, and age at starting smoking (Table 3).
Age at Starting To Smoke
Current Smokers
We examined the relation between age at starting smoking and risk for total and cause-specific mortality among current smokers (Table 4). The relative risk for total mortality among current smokers who started smoking before age 15 years was 2.80 (CI, 2.05 to 3.82), whereas for those who started after age 26 years, the relative risk was 1.59 (CI, 1.28 to 1.97) (P = 0.01). Starting to smoke before the age of 15 years was associated with the highest risks for death from cardiovascular disease (age-adjusted relative risk, 8.72; CI, 5.58 to 13.65), and external causes of injury (age-adjusted relative risk, 3.22; CI, 1.37 to 7.55). Adjusting for multiple risk factors, including the daily number of cigarettes smoked, did not substantially affect these observations (Table 4).
|
Former Smokers
Among former smokers the relation between age at starting smoking and the risks for total and cause-specific mortality were not statistically significant. These observations remained unchanged after adjusting for multiple risk factors, including the number of cigarettes smoked per day and the time since quitting.
The "Ill Quitter" Effect
Previous studies have suggested that recent quitters include a disproportionate number of those who have quit because they are ill [7]. The effect of this is to cause a spuriously elevated risk for death among former smokers during the early years after cessation. To address this problem, we did analyses in which women who reported nonfatal cardiovascular disease (myocardial infarction, angina, stroke) or cancer (excluding nonmelanoma skin cancer) at each biennial questionnaire were excluded from further follow-up. These exclusions left a total of 1980 deaths for analysis (Appendix Tables 1 and 2). Among current smokers, the strength of the association between the daily number of cigarettes smoked and the risk for total mortality increased after excluding diseases at the beginning of each 2-year interval (Appendix Table 1). When we examined the relation of time since quitting with risk for cancer mortality (including and excluding lung cancer), an excess risk was no longer apparent among former smokers within the first 2 years after quitting, suggesting an association between cancer diagnosis and stopping smoking.
|
|
As we explained in the Methods section, in a prospective study involving repeated measurement of smoking status, nonfatal disease may act simultaneously as a confounding factor and an intermediate variable in the pathway between smoking and death [24, 25]. We assessed the extent of such confounding by applying a method previously described [24, 25] to the association between cigarette smoking and fatal coronary heart disease, with nonfatal myocardial infarction as the intermediate variable. When we did this analysis, the risk estimate for coronary heart disease mortality was identical to the crude estimate of risk. Therefore we concluded that confounding by intermediate variables was unlikely to be of major concern in our study.
Confounding by Alcohol Intake and Vigorous Exercise
To examine the possible confounding effects of alcohol consumption and vigorous exercise on cigarette smoking, we analyzed data from the 1980 to 1988 follow-up interval. Although the analysis was limited to 2356 deaths, the age-adjusted association between daily number of cigarettes smoked and the risk for total mortality remained unchanged. The relative risk for total mortality increased from 1.56 (CI, 1.28 to 1.91) among women smoking 1 to 14 cigarettes per day to 2.53 (CI, 1.95 to 3.24) among women smoking 35 or more cigarettes per day. After adjusting for alcohol consumption and vigorous exercise, the risk for total mortality among former smokers still declined to the level of never smokers 10 to 14 years after cessation.
Adjusting for alcohol intake and vigorous exercise resulted in a slight strengthening of the association between current smoking and cardiovascular disease mortality. For example, the multivariate relative risk for cardiovascular disease mortality increased from 2.69 to 3.08 among women smoking 1 to 14 cigarettes per day and from 4.28 to 4.93 among women smoking 25 to 34 cigarettes per day. However, the excess risk for death from cardiovascular disease among former smokers still took 10 to 14 years to decline to the level of never smokers.
The risk for death from external causes of injury among current smokers compared with never smokers declined from 1.69 (CI, 1.28 to 2.24) to 1.54 (CI, 1.10 to 2.17) after adjusting for alcohol intake and vigorous exercise. The excess risk among former smokers approached the level of never smokers 5 to 9 years after quitting.
Discussion
|
|---|
|
|
|---|
The time required for the risk for total mortality among quitters to reach the level of never smokers differs across studies. The Nurses' Health Study data indicate that the risk among former smokers decreases to the level of never smokers 10 to 14 years after cessation. This estimate of the time required is somewhat shorter than that of several previous studies. For example, the American Cancer Society Cancer Prevention Study I (ACS CPS-I) found that among former smokers of 20 or more cigarettes per day, the risk for total mortality was still higher than that of never smokers even after 10 years of abstinence [6]. In the more recent ACS CPS-II study, involving 4 years of follow-up among 521 555 men and 658 748 women, the risk for total mortality among female former smokers decreased to the level of never smokers 16 or more years after cessation [7]; and in the U.S. Veterans Study [10], the overall mortality risk among male smokers remained elevated 15 years or more after cessation (among smokers of 10 to 20 cigarettes per day, relative risk, 1.47; among smokers of 21 to 39 cigarettes per day, relative risk, 1.22).
The differences among studies in estimates of the duration needed for a former smoker to have the same overall mortality risk as a never smoker may be caused partly by factors such as the lack of ascertainment of smoking status after enrollment in earlier studies [6, 7, 10]. In these studies, persons who smoked at enrollment but subsequently quit remained assigned to the current smoker category. This misclassification tends to obscure the benefits of cessation in comparison with continued smoking [7]. In contrast, another study [9], which updated smoking status at yearly intervals, reported that the relative risk for total mortality among women who formerly smoked returned to the level of never smokers 6 to 10 years after cessation.
A potential limitation of our study is that our cohort consists of predominantly white middle-aged female nurses. Although our findings might not be generalizable to older women or other ethnic groups, the qualitatively similar effects of smoking across population subgroups defined by age, sex, and race suggest that the biological effects of smoking cessation are also not likely to differ in major ways across demographic groups. Smokers who quit may be unrepresentative in ways that could not be controlled in our analysis, although we adjusted for a broad range of potential confounding variables in our multivariate analyses. Finally, during the 12-year follow-up period, current smokers were marginally less likely to respond compared with former smokers. This could have potentially resulted in under-estimation of the benefits of cessation. The difference in response rates, however, never exceeded 0.5 percentage points, making this an unlikely source of major bias.
The observation of an excess cancer mortality risk within the first 2 years of giving up smoking in our study (see Table 3) and in previous studies [7] has been attributed to the "ill quitter" effect. When analyses excluded women with cardiovascular disease and cancer at the beginning of each 2-year follow-up interval, the excess risk among recent quitters was removed. The data in Appendix Tables 1 and 2 provide a comparison between the effect of stopping smoking before developing disease and the situation in which a proportion of smokers stop after the onset of disease. The benefits of smoking cessation, in terms of a reduction in all-cause as well as cause-specific mortality, occur sooner in the former case. If a smoker stops smoking before the onset of disease, she will experience a 24% reduction in the risk for total mortality within 2 years of quitting (including a 37% reduction in cardiovascular disease mortality) as well as a rapid decline of the risk for cancer mortality to the level of a never smoker (Appendix Table 2). These benefits are more substantial and occur sooner than in the case of delaying the cessation of smoking until the onset of disease (Table 3).
The finding of an association between cigarette smoking and suicide and accidents has been reported in previous studies, including the British Doctors study [8] and the MRFIT study [29]. To our knowledge, our study is the first to report the relationships of age at starting smoking and time since quitting with risk for deaths from external causes of injury. Although a recent study dismissed the association as causal because of lack of biological plausibility [29], several studies have shown an association between cigarette smoking and depression [30-33]. The Nurses' Health Study collected no data on the mental health of participants before 1992. On the other hand, the association between smoking and external causes of injury persisted after controlling for alcohol intake in multivariate analysis. Whether this association is causal or whether smoking is merely correlated with one or more factors (as yet unidentified) predisposing to accidents and suicide deserves further study.
Weight gain after smoking cessation is thought to be a factor contributing to continuing smoking by women [7]. In the Nurses' Health Study, women who quit smoking had on average 1.4 to 2.8 kg greater weight gain during an 8-year follow-up period compared with continuing smokers [34]. Our analyses of total mortality, which balance any adverse as well as desirable effects of smoking cessation, clearly indicate that the health benefits of smoking cessation far exceed the risks posed by this amount of weight gain.
The best health advice remains not to start smoking at all, particularly at a young age. Benefits of smoking cessation are substantial, however, and begin to accrue almost immediately after quitting.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking. A second report on the mortality of British doctors. Br Med J. 1956; 2:1071-81.
2. Hammond EC, Horn D. Smoking and death rates. Report on forty-four months of follow-up on 187,783 men. I. Total mortality. JAMA. 1958; 166:1159-72.
3. Dunn JE Jr, Linden G, Breslow L. Lung cancer mortality experience of men in certain occupations in California. Am J Public Health. 1960; 50:1475-87.
4. Best EW, Josie GH, Walker CB. A Canadian study of mortality in relation to smoking habits. A preliminary report. Can J Public Health. 1961; 52:99-106.
5. Kahn HA. The Dorn study of smoking and mortality among US veterans: report on eight and one-half years of observation. In: Haenszel W; ed. Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. National Cancer Institute Monograph 19. U.S. Department of Health, Education, and Welfare, Public Health Service, National Cancer Institute; 1966:1-125.
6. Hammond EC. Smoking in relation to the death rates of one million men and women. In: Haenszel W; ed. Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases, National Cancer Institute Monograph 19. U.S. Department of Health, Education, and Welfare, Public Health Service, National Cancer Institute; 1966:127-204.
7. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS publication no. (CDC) 90-8416; 1990.
8. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations of male British doctors. Br Med J. 1976; 2:1525-36.
9. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, et al. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991; 324:1619-25.
10. Rogot E, Murray JL. Smoking and causes of death among US veterans: 16 years of observation. Public Health Rep. 1980; 95:213-22.
11. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J. 1980; 280:967-71.
12. Hennekens CH, Speizer FE, Rosner B, Bain CJ, Belanger C, Peto R. Use of permanent hair dyes and cancer among registered nurses. Lancet. 1979; 1:1301-3.
13. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985; 313:1044-9.
14. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988; 319: 267-73.
15. Rimm EB, Giovannucci E, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338:464-8.
16. Colditz GA, Willett WC, Stampfer MJ, Sampson L, Rosner B, Hennekens CH, et al. The influence of age, relative weight, smoking, and alcohol intake on the reproducibility of a dietary questionnaire. Int J Epidemiol. 1987; 16:392-8.
17. Giovannucci E, Colditz GA, Stampfer MJ, Rimm ER, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991; 133:810-7.
18. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990; 132: 612-28.
19. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991; 338:774-8.
20. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, et al. Test of the National Death Index. Am J Epidemiol. 1984; 119:837-9.
21. Miettinen O. Estimation and estimability in case-referent studies. Am J Epidemiol. 1976; 103:226-35.
22. Rothman KJ, Boice JD Jr. Epidemiologic analysis with a programmable calculator. NIH publication no.79-1649. Washington, DC: Public Health Service; 1979.
23. Myers AH, Rosner B, Abbey H, Willett WC, Stampfer MJ, Bain C, et al. Smoking behavior among participants in the Nurses' Health Study. Am J Public Health. 1987; 77:628-30.
24. Robins J. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J Chronic Dis. 1987; 40(Suppl 2):139S-61S.
25. Robins J. The control of confounding by intermediate variables. Stat Med. 1989; 8:679-701.
26. U.S. Department of Health, Education, and Welfare. International Classification of Diseases, v 1: Tabular List. Eighth revision. PHS publication no. 1693. Washington, DC: Public Health Service; 1972.
27. U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. PHS publication no. 1693. DHHS Publication No. (CDC) 89-8411. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office for Smoking and Health; 1989.
28. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992; 339:1268-78.
29. Davey Smith G, Phillips AN, Neaton JD. Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet. 1992; 340:709-12.
30. Perez-Stable EJ, Martin G, Martin BV, Katz MH. Depressive symptoms and cigarette smoking among Latinos in San Francisco. Am J Public Health. 1990; 80:1500-2.
31. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation and major depression. JAMA. 1990; 264:1546-9.
32. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. JAMA. 1990; 264:1541-5.
33. Glass RM. Blue mood, blackened lungs. JAMA 1990; 264:1583-4.
34. Colditz GA, Segal MR, Myers AH, Stampfer MJ, Willett WC, Speizer FE. Weight change in relation to smoking cessation among women. Journal of Smoking-Related Diseases. 1992; 3:145-53.
This article has been cited by other articles:
![]() |
G. A. Colditz and D. M. Winn Criteria for the Evaluation of Large Cohort Studies: An Application to the Nurses' Health Study J Natl Cancer Inst, July 2, 2008; 100(13): 918 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kenfield, M. J. Stampfer, B. A. Rosner, and G. A. Colditz Smoking and Smoking Cessation in Relation to Mortality in Women JAMA, May 7, 2008; 299(17): 2037 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T Streppel, H. C Boshuizen, M. C Ocke, F. J Kok, and D. Kromhout Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: The Zutphen Study Tob. Control, April 1, 2007; 16(2): 107 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Derdeyn Carotid Stenting for Asymptomatic Carotid Stenosis: Trial It Stroke, February 1, 2007; 38(2): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. James, M. G. Jamison, M. S. Biswas, L. R. Brancazio, G. K. Swamy, and E. R. Myers Acute Myocardial Infarction in Pregnancy: A United States Population-Based Study Circulation, March 28, 2006; 113(12): 1564 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Vollset, A. Tverdal, and H. K. Gjessing Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med, March 21, 2006; 144(6): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF] |
||||
![]() |
S. A. Schroeder What to Do With a Patient Who Smokes JAMA, July 27, 2005; 294(4): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Wen, S P Tsai, T Y Cheng, H T Chan, W S I Chung, and C J Chen Excess injury mortality among smokers: a neglected tobacco hazard Tob. Control, June 1, 2005; 14(suppl_1): i28 - i32. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iso, C. Date, A. Yamamoto, H. Toyoshima, Y. Watanabe, S. Kikuchi, A. Koizumi, Y. Wada, T. Kondo, Y. Inaba, et al. Smoking Cessation and Mortality from Cardiovascular Disease among Japanese Men and Women: The JACC Study Am. J. Epidemiol., January 15, 2005; 161(2): 170 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. B. Knoops, L. C. P. G. M. de Groot, D. Kromhout, A.-E. Perrin, O. Moreiras-Varela, A. Menotti, and W. A. van Staveren Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality in Elderly European Men and Women: The HALE Project JAMA, September 22, 2004; 292(12): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsiara, M. Elisaf, and D. P. Mikhailidis Influence of Smoking on Predictors of Vascular Disease Angiology, September 1, 2003; 54(5): 507 - 530. [Abstract] [PDF] |
||||
![]() |
N. S. Godtfredsen, C. Holst, E. Prescott, J. Vestbo, and M. Osler Smoking Reduction, Smoking Cessation, and Mortality: A 16-year Follow-up of 19,732 Men and Women from the Copenhagen Centre for Prospective Population Studies Am. J. Epidemiol., December 1, 2002; 156(11): 994 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haveman-Nies, L. P. G. M. de Groot, J. Burema, J. A. A. Cruz, M. Osler, and W. A. van Staveren Dietary Quality and Lifestyle Factors in Relation to 10-Year Mortality in Older Europeans: The SENECA Study Am. J. Epidemiol., November 15, 2002; 156(10): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lan, R. S. Chapman, D. M. Schreinemachers, L. Tian, and X. He Household Stove Improvement and Risk of Lung Cancer in Xuanwei, China J Natl Cancer Inst, June 5, 2002; 94(11): 826 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
The United Kingdom Small Aneurysm Trial Participan Long-Term Outcomes of Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysms N. Engl. J. Med., May 9, 2002; 346(19): 1445 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bolego, A. Poli, and R. Paoletti Smoking and gender Cardiovasc Res, February 15, 2002; 53(3): 568 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Al-Delaimy, J. E. Manson, C. G. Solomon, I. Kawachi, M. J. Stampfer, W. C. Willett, and F. B. Hu Smoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus Arch Intern Med, February 11, 2002; 162(3): 273 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Al-Delaimy, W. C. Willett, J. E. Manson, F. E. Speizer, and F. B. Hu Smoking and Mortality Among Women With Type 2 Diabetes: The Nurses' Health Study cohort Diabetes Care, December 1, 2001; 24(12): 2043 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. LIPSHULTZ, S. D. FISHER, W. W. LAI, and T. L. MILLER Cardiovascular Monitoring and Therapy for HIV-Infected Patients Ann. N.Y. Acad. Sci., November 1, 2001; 946(1): 236 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Pelkonen, I-L Notkola, H Tukiainen, M Tervahauta, J Tuomilehto, and A Nissinen Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study Thorax, September 1, 2001; 56(9): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q Qiao, M Tervahauta, A Nissinen, and J Tuomilehto Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men Eur. Heart J., October 1, 2000; 21(19): 1621 - 1626. [Abstract] [PDF] |
||||
![]() |
M. Pelkonen, H. Tukiainen, M. Tervahauta, I.-L. Notkola, S.-L. Kivelä, Y. Salorinne, and A. Nissinen Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men Thorax, September 1, 2000; 55(9): 746 - 750. [Abstract] [Full Text] |
||||